Related Experiment Video

Updated: May 24, 2026

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model
08:06

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

Defective death receptor signaling as a cause of tumor immune escape

Lars E French1, Jürg Tschopp

  • 1Department of Dermatology, Geneva University Hospital, Switzerland.

Seminars in Cancer Biology
|April 3, 2002
PubMed

Insights

Defective Fas signaling, caused by receptor issues or FLIP inhibition, hinders Fas-mediated tumor cell death. This interference allows tumors to evade immune system detection and destruction.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • Death receptors, part of the TNF-receptor superfamily, initiate apoptosis via caspase-8 activation.
  • Fas (CD95) and its ligand are crucial for immune homeostasis and effector functions.
  • Fas-mediated apoptosis is a key mechanism for cytotoxic T-cells to eliminate tumor cells.

Purpose of the Study:

  • To investigate how defects in Fas signaling impact tumor immune escape.
  • To explore the role of receptor downregulation, dysfunction, and FLIP inhibition in Fas-mediated tumor cell death.

Main Methods:

  • Review of recent investigations on Fas signaling pathways.
  • Analysis of mechanisms leading to defective Fas signaling.
  • Examination of the consequences of impaired Fas-mediated apoptosis.

Main Results:

  • Defective Fas signaling, through receptor downregulation or dysfunction, impairs tumor cell apoptosis.
  • Intracellular inhibition by FLICE inhibitory protein (FLIP) also disrupts Fas-mediated cell death.
  • These defects facilitate tumor immune escape by preventing targeted cell death.

Conclusions:

  • Impaired Fas signaling is a significant mechanism by which tumors evade immune surveillance.
  • Targeting Fas pathway defects or FLIP could potentially restore anti-tumor immunity.

More Related Videos

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.